Cargando…
Methylation factor MRPL15 identified as a potential biological target in Alzheimer’s disease
Alzheimer’s disease (AD) is the most common form of dementia. However, the molecular basis of the development and progression of AD is still unclear. To elucidate the molecular processes related to AD, we obtained the expression profiles and analyzed the differentially expressed genes (DEGs). The ge...
Autores principales: | Gao, Li, Li, Jianmei, Yan, Ming, Aili, Maimaiti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202902/ https://www.ncbi.nlm.nih.gov/pubmed/34016794 http://dx.doi.org/10.18632/aging.202862 |
Ejemplares similares
-
MRPL15 is a novel prognostic biomarker and therapeutic target for epithelial ovarian cancer
por: Xu, Haoya, et al.
Publicado: (2021) -
Prognostic Value and Related Regulatory Networks of MRPL15 in Non-Small-Cell Lung Cancer
por: Zeng, Yangyang, et al.
Publicado: (2021) -
MRPL42 is activated by YY1 to promote lung adenocarcinoma progression
por: Jiang, Wei, et al.
Publicado: (2021) -
Insufficiency of Mrpl40 disrupts testicular structure and semen parameters in a murine model
por: Liu, Ying, et al.
Publicado: (2023) -
MRPL51 is a downstream target of FOXM1 in promoting the malignant behaviors of lung adenocarcinoma
por: Zhang, Wenqian, et al.
Publicado: (2023)